In vitro effects of 2‐methyl‐3‐propylbutane‐1, 4‐diol purified from Alstonia boonei on erythrocyte membrane stabilization and mitochondrial membrane permeabilization. (15th November 2022)
- Record Type:
- Journal Article
- Title:
- In vitro effects of 2‐methyl‐3‐propylbutane‐1, 4‐diol purified from Alstonia boonei on erythrocyte membrane stabilization and mitochondrial membrane permeabilization. (15th November 2022)
- Main Title:
- In vitro effects of 2‐methyl‐3‐propylbutane‐1, 4‐diol purified from Alstonia boonei on erythrocyte membrane stabilization and mitochondrial membrane permeabilization
- Authors:
- Olanlokun, John Oludele
Oyebode, Olubukola Titilope
Popoola, David
Bodede, Olusola
Idowu, Thomas Oyebode
Moodley, Roshila
Olorunsogo, Olufunso Olabode - Abstract:
- Abstract: A recent review on the ethnomedicinal, chemical, pharmacological, and toxicological properties of Alstonia boonei revealed the plant's potential in the treatment and management of a range of diseases. However, most of these pharmacological effects are only traceable to the crude form of the plant extract and not specific natural products. Phytochemical investigation of the methanol fraction of the methanol extract of the stem‐bark of Alstonia boonei led to the isolation and identification of 2‐methyl‐3‐propylbutane‐1, 4‐diol. The structures were elucidated by the application of 1D‐, and 2D‐NMR spectroscopic analyses and by comparison with literature data. In this study, the membrane stabilizing activity, mitochondrial membrane permeability transition pore opening, cytochrome c release, mitochondrial ATPase activity, and prevention of mitochondrial lipid peroxidation activity of 2‐methyl‐3‐propylbutane‐1, 4‐diol (MPBD) isolated from A. boonei were determined. The results showed that MPBD significantly ( p < .05) prevented peroxidation of mitochondrial membrane lipids and hemolysis using both the heat‐induced and hypotonic solution‐induced membrane stabilization assays. On the contrary, the compound caused large amplitude swelling of rat liver mitochondria in the absence of calcium, significant ( p < .05) cytochrome c release and enhancement of mitochondrial ATPase activity in vitro . Our findings suggest that MPBD showed characteristic biological properties usefulAbstract: A recent review on the ethnomedicinal, chemical, pharmacological, and toxicological properties of Alstonia boonei revealed the plant's potential in the treatment and management of a range of diseases. However, most of these pharmacological effects are only traceable to the crude form of the plant extract and not specific natural products. Phytochemical investigation of the methanol fraction of the methanol extract of the stem‐bark of Alstonia boonei led to the isolation and identification of 2‐methyl‐3‐propylbutane‐1, 4‐diol. The structures were elucidated by the application of 1D‐, and 2D‐NMR spectroscopic analyses and by comparison with literature data. In this study, the membrane stabilizing activity, mitochondrial membrane permeability transition pore opening, cytochrome c release, mitochondrial ATPase activity, and prevention of mitochondrial lipid peroxidation activity of 2‐methyl‐3‐propylbutane‐1, 4‐diol (MPBD) isolated from A. boonei were determined. The results showed that MPBD significantly ( p < .05) prevented peroxidation of mitochondrial membrane lipids and hemolysis using both the heat‐induced and hypotonic solution‐induced membrane stabilization assays. On the contrary, the compound caused large amplitude swelling of rat liver mitochondria in the absence of calcium, significant ( p < .05) cytochrome c release and enhancement of mitochondrial ATPase activity in vitro . Our findings suggest that MPBD showed characteristic biological properties useful in modulating cell death. Abstract : Alkane diol purified from Alstonia boonei has modulatory effects on mitochondria, enhance mitochondrial ATPase activity and cytochrome c release; it also prevented hemolysis. … (more)
- Is Part Of:
- Chemical biology & drug design. Volume 101:Number 3(2023)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 101:Number 3(2023)
- Issue Display:
- Volume 101, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 101
- Issue:
- 3
- Issue Sort Value:
- 2023-0101-0003-0000
- Page Start:
- 678
- Page End:
- 689
- Publication Date:
- 2022-11-15
- Subjects:
- Alstonia boonei -- cytochrome c -- lipid peroxidation -- mitochondria -- mitochondrial adenosine triphosphatase
Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.14168 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 25728.xml